🔎 Trials Near Me

Home › Idiopathic Pulmonary Fibrosis › Kansas › Kansas City

Idiopathic Pulmonary Fibrosis clinical trials in Kansas City, KS

7 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

RecruitingPhase 2
  • The University of Kansas Medical Center, Kansas City
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

RecruitingPhase 2
  • Research Site, Kansas City
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

RecruitingPhase 2
  • The University of Kansas Medical Center, Kansas City
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

RecruitingPhase 2
  • University of Kansas Medical Center, Kansas City
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

RecruitingPhase 2
  • University of Kansas, Kansas City
Ages 40 and older · All sexes · Updated Sep 2, 2026 · NCT05571059

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

RecruitingPhase 2
  • WISPer site in Kansas City, KS, Kansas City
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805

Interstitial Lung Disease Research Unit Biobank

RecruitingObservational study
  • The University of Kansas Medical Center, Kansas City
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05392881

Idiopathic Pulmonary Fibrosis trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.